Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study

Alphs, 2013, Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics, Neuropsychiatr Dis Treat, 9, 341, 10.2147/NDT.S36438

10.1176/appi.ajp.162.3.441

10.1001/jamapsychiatry.2015.0241

10.1186/1471-244X-12-26

10.1056/NEJMoa002028

10.1016/j.clinthera.2008.12.020

10.1093/schbul/sbu006

10.1097/YIC.0b013e32833948fa

10.1177/0269881110372817

Guy W (1976) ECDEU assessment manual for psychopharmacology: revised (DHEW publication number ADM 76–338). Rockville, MD: US Department of Health, Education and Welfare, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, pp 534–537.

10.1176/appi.ajp.163.2.185

10.1177/2045125312474019

10.1016/j.schres.2009.10.026

10.1016/j.pnpbp.2009.05.014

Invega Sustenna Prescribing Information (2015) https://www.janssencns.com/shared/product/invegasustenna/prescribing-information.pdf Last updated in June 2015.

Invega Trinza Prescribing Information (2015) http://www.janssencns.com/shared/product/invegatrinza/prescribing-information.pdf last updated in May 2015.

10.1017/S1461145709990988

10.1176/appi.ajp.160.7.1209

10.4088/JCP.v67n0103

10.1038/npp.2010.79

10.1097/JCP.0b013e3181dd3103

10.1007/s40263-013-0083-9